Wang, David <br/><br/>
Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity.  [electronic resource] 

 -  Cell reports  06 2018 
 - 3262-3274 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2211-1247 
<br/><br/><label>Standard No.: </label>10.1016/j.celrep.2018.05.050  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>CD4-Positive T-Lymphocytes--cytology<br/>CD8-Positive T-Lymphocytes--cytology<br/>Cell Line, Tumor<br/>Enhancer of Zeste Homolog 2 Protein--deficiency<br/>Forkhead Transcription Factors--metabolism<br/>Humans<br/>Interferon-gamma--metabolism<br/>Lymphocytes, Tumor-Infiltrating--cytology<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Knockout<br/>Neoplasms--immunology<br/>T-Lymphocytes, Regulatory--cytology<br/>Tumor Microenvironment<br/>Tumor Necrosis Factor-alpha--metabolism